Pharma.Aero, whose aim is to achieve excellence in the reliable, end-to-end air transportation and handling of high-value, time-sensitive pharmaceutical products, announced Cathay Pacific’s full membership at the recently held IATA World Cargo Symposium in Singapore. Accordingly, now Cathay Pacific has become a full member of Pharma.Aero, a cross-industry collaboration for pharma shippers, CEIV-certified cargo communities, airport operators and other air cargo industry stakeholders. Cathay Pacific has been CEIV Pharma certified since October 2017.
IATA created the Center of Excellence for Independent Validators in Pharmaceutical Logistics (CEIV Pharma), to help organizations and the entire air cargo supply chain to get on the right track to achieve pharmaceutical handling excellence. CEIV Pharma addresses industry’s need for more safety, security, compliance and efficiency, by the creation of a globally consistent and recognized pharmaceutical product handling certification.
According to Mr Rajesh Menon, Cathay Pacific Regional Head of Cargo for South Asia, Middle East and Africa, India and Bangladesh are both big markets for Cathay Pacific, especially when it comes to shipments of pharmaceutical products. Hyderabad, Bangalore and Mumbai followed by Dhaka have always had large number of pharma shipments and this continues to grow. United States, Canada and Australia are key trade lanes for India and Bangladesh. “PharmaLIFT is an important product and our handling expertise is a key USP we provide to our agents. Collaborating with Pharma.Aero, this offering will only become stronger to provide quality in the transportation and expert handling of valuable and sensitive pharmaceutical products.”
Pharmaceutical shipments travelling the corridor will be handled in strict compliance with the IATA’s CEIV Pharma standard. “Shippers will be assured of seamless airport-to-airport (A2A) temperature-controlled handling, assuring the integrity of the shipments,” said Cathay Pacific sources.